Heres a situation every somatotropic researcher eventually runs into: three compounds on the shelf, all of them secretagogues, all hitting GHSR-1a and the protocol decision matters more than most people initially realize
While tirzepatide (Zepbound and Mounjaro) currently leads in terms of average weight loss in approved medications, CagriSema could become a strong competitor once Phase 3 results are released
*Products containing ALA (Total Eye Care, Total Care Daily Formula, ALA/ALC/Carnosine/GSE) are not allowed for import in Norway
Neurology 101 (14), e1391e1401
and stay up to date on current health topics and new research
Semaglutide is a glucagon-like peptide-1 receptor agonist (GLP-1) medication prescribed to manage Type 2 diabetes, reduce the risk of cardiovascular events like heart attacks, and assist with chronic weight management